Boston Scientific Surges 0.27% on $764M Volume as High-Volume Stocks Power 166.71% Strategy Return

On July 30, 2025, Boston Scientific (BSX) closed up 0.27% at $106.76, with a trading volume of $764.64 million. The stock fluctuated 1.28% between a low of $105.88 and a high of $107.23, maintaining a two-week gain of 3.46%. Volume increased by 2 million shares compared to the prior day, signaling positive technical momentum.

Technical indicators suggest a mixed outlook. Short- and long-term moving averages align with a buy signal, with support levels at $106.05 and $103.62. However, a double top formation identified on July 23 triggered a sell signal, projecting a potential decline to $100.72 within 16 trading days. The stock remains within a horizontal trend range of $99.94–$108.80, with a 90% probability of staying within these bounds over the next three months.

Analysts highlight accumulated volume support at $106.53, suggesting potential upward movement if the level holds. While liquidity and volatility remain controlled, a breakdown below key support levels could trigger further sell-offs. The MACD indicator and rising volume add to the bullish case, though near-term corrections remain a risk.

Backtest results for a strategy buying the top 500 high-volume stocks and holding for one day showed a 166.71% return from 2022 to the present, outperforming the benchmark by 137.53%. The approach achieved a compound annual growth rate of 31.89%, underscoring the potential of liquidity-driven strategies in capturing market sentiment-driven gains.